Response to "New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019"

Florence Assan¹, Emilie Sbidian^{2

3}, Hervé Bachelez^{1

4}

Affiliations

¹ Université de Paris, Paris, France; INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Institut Imagine, University of Paris, Paris, France.
² Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
³ Hôpital Henri Mondor, Clinical Investigation Centre, Créteil, France; Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) - EA 7379, Créteil, France.
⁴ Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.

Florence Assan et al. JAAD Case Rep. 2021 May.

. 2021 May:11:130-131.

doi: 10.1016/j.jdcr.2021.02.024. Epub 2021 Mar 4.

Florence Assan¹, Emilie Sbidian^{2

3}, Hervé Bachelez^{1

4}

¹ Université de Paris, Paris, France; INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Institut Imagine, University of Paris, Paris, France.
² Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
³ Hôpital Henri Mondor, Clinical Investigation Centre, Créteil, France; Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) - EA 7379, Créteil, France.
⁴ Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.

No abstract available

Keywords: GPP, generalized pustular psoriasis; RV, respiratory viruses.

Conflict of interest statement

None disclosed.

1. Mathieu R.J., Cobb C.B.C., Telang G.H., Firoz E.F. New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019. JAAD Case Rep. 2020;6(12):1360–1362. - PMC - PubMed
1. Sbidian E., Madrange M., Viguier M. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol. 2019;181(6):1304–1306. - PMC - PubMed
1. Marrakchi S., Guigue P., Renshaw B.R. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620–628. - PubMed
1. Catapano M., Vergnano M., Romano M. IL-36 promotes systemic IFN-I responses in severe forms of psoriasis. J Invest Dermatol. 2020;140(4):816–826.e3. - PMC - PubMed
1. Zhang Q., Bastard P., Liu Z. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. - PMC - PubMed